Clinical Trials Directory

Trials / Conditions / Childhood High-grade Cerebral Astrocytoma

Childhood High-grade Cerebral Astrocytoma

13 registered clinical trials studyying Childhood High-grade Cerebral Astrocytoma.

StatusTrialSponsorPhase
TerminatedPalbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervou
NCT02255461
Pediatric Brain Tumor ConsortiumPhase 1
Terminated18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas
NCT02175745
Erik MittraN/A
WithdrawnEfficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
NCT02194452
Sue O'DorisioN/A
CompletedVorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spi
NCT01076530
National Cancer Institute (NCI)Phase 1
CompletedABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors
NCT00946335
National Cancer Institute (NCI)Phase 1
CompletedCilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responde
NCT00679354
National Cancer Institute (NCI)Phase 2
CompletedIspinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma
NCT00363272
National Cancer Institute (NCI)Phase 1
CompletedLenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors
NCT00100880
National Cancer Institute (NCI)Phase 1
CompletedOxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatme
NCT00091182
National Cancer Institute (NCI)Phase 2
CompletedTipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primit
NCT00070525
National Cancer Institute (NCI)Phase 2
CompletedCilengitide in Treating Children With Refractory Primary Brain Tumors
NCT00063973
National Cancer Institute (NCI)Phase 1
CompletedTemozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors
NCT00052780
National Cancer Institute (NCI)Phase 1
CompletedFR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia
NCT00053963
National Cancer Institute (NCI)Phase 1